iShares Neuroscience and Healthcare ETF
IBRN
4 hedge funds and large institutions have $2.08M invested in iShares Neuroscience and Healthcare ETF in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
13.69% less ownership
Funds ownership: 77.01% → 63.32% (-14%)
19% less capital invested
Capital invested by funds: $2.58M → $2.08M (-$503K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.85K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$260K |
| 2 |
BlackRock
New York
|
-$196K |
IBRN Hedge Fund Activity: Q2 2025 in Review
4 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in iShares Neuroscience and Healthcare ETF (IBRN) for Q2 2025, worth a combined $2.08M — down 19% from $2.58M a quarter earlier.
Fund positioning in IBRN was balanced in Q2 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $1.85K. The largest seller was Flow Traders U.S., exiting entirely with an estimated $260K sold.
- 4 institutional investors held iShares Neuroscience and Healthcare ETF (IBRN) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $2.08M of iShares Neuroscience and Healthcare ETF stock for Q2 2025, down 19% quarter-over-quarter.
- 1 fund opened new iShares Neuroscience and Healthcare ETF positions in Q2 2025 and 1 closed out, a net change of 0 holders.
- The largest iShares Neuroscience and Healthcare ETF buyer in Q2 2025 was UBS Group, an estimated $1.85K added.
- The largest iShares Neuroscience and Healthcare ETF seller in Q2 2025 was Flow Traders U.S., an estimated $260K sold.
Based on aggregated 13F filings for Q2 2025.